Orion Genomics


Jun 11, 08

NEW STORY
08:00 ET Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University

 
Dec 20, 07

08:00 ET Orion Genomics Announces the Discovery of Novel Breast Cancer Biomarkers

 
Nov 16, 06

08:00 ET Orion Genomics Announces Notice of Allowance for U.S. Patent Covering Genome Wide Novel Biomarker Discovery Platform, MethylScope(R)

 
Jun 13, 06

08:00 ET Orion Genomics Scientific Co-Founder Rob Martienssen Appointed Fellow of the Royal Society of London

 
Jan 20, 06

09:00 ET Researchers at Orion Genomics and University of Glasgow Collaborate to Identify Epigenetic Biomarkers for Early Cancer Diagnosis and Personalized Therapy Selection

 
Aug 09, 05

09:03 ET Researchers at Orion Genomics and Washington University in St. Louis Collaborate to Uncover DNA's 'Second Code' for Development of New Cancer Tests

 
Jul 19, 05

09:05 ET Orion Genomics Appoints Jorge Leon, Ph.D., to Board of Directors

 
Jun 07, 05

09:04 ET Orion Genomics and Andrew Feinberg, M.D., Collaborate to Explore the Role of DNA's 'Second Code' in Colon Cancer

 


Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.
Terms and conditions, including restrictions on redistribution, apply.
Copyright © 1996-2008 PR Newswire Association LLC. ALL Rights Reserved.
A United Business Media company.